{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260327933390/en/Multiple-Ivonescimab-Data-Sets-from-Phase-III-Studies-in-Advanced-NSCLC-Patient-Populations-to-be-Featured-at-ELCC-2026", "message": "News view counter 628888 successfully enlarged"}